131 related articles for article (PubMed ID: 11117769)
1. Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites.
Perry W; Wiseman RA
BJOG; 2000 Nov; 107(11):1401-6. PubMed ID: 11117769
[TBL] [Abstract][Full Text] [Related]
2. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential oestrogen/progestin treatment.
Pors Nielsen S; Bärenholdt O; Hermansen F; Munk-Jensen N
Br J Obstet Gynaecol; 1994 Apr; 101(4):319-24. PubMed ID: 8199078
[TBL] [Abstract][Full Text] [Related]
3. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women.
Studd JW; Holland EF; Leather AT; Smith RN
Br J Obstet Gynaecol; 1994 Sep; 101(9):787-91. PubMed ID: 7947528
[TBL] [Abstract][Full Text] [Related]
4. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants.
Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R
Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.
Rubinacci A; Peruzzi E; Modena AB; Zanardi E; Andrei B; De Leo V; Pansini FS; Quebe-Fehling E; de Palacios PI
Menopause; 2003; 10(3):241-9. PubMed ID: 12792297
[TBL] [Abstract][Full Text] [Related]
6. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Mc Manus J; Mc Eneny J; Thompson W; Young IS
Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
[TBL] [Abstract][Full Text] [Related]
7. The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women.
Dresner-Pollak R; Mayer M; Hochner-Celiniker D
Calcif Tissue Int; 2000 Feb; 66(2):104-7. PubMed ID: 10652956
[TBL] [Abstract][Full Text] [Related]
8. The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women.
Pereda CA; Hannon RA; Naylor KE; Eastell R
BJOG; 2002 Jul; 109(7):812-20. PubMed ID: 12135219
[TBL] [Abstract][Full Text] [Related]
9. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
Stevenson JC; Cust MP; Gangar KF; Hillard TC; Lees B; Whitehead MI
Lancet; 1990 Aug; 336(8710):265-9. PubMed ID: 1973969
[TBL] [Abstract][Full Text] [Related]
10. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women.
Eiken P; Kolthoff N; Nielsen SP
Bone; 1996 Nov; 19(5 Suppl):191S-193S. PubMed ID: 8922661
[TBL] [Abstract][Full Text] [Related]
11. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
Hirvonen E; Cacciatore B; Wahlström T; Rita H; Wilén-Rosenqvist G
Br J Obstet Gynaecol; 1997 Nov; 104 Suppl 16():26-31. PubMed ID: 9389780
[TBL] [Abstract][Full Text] [Related]
12. Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
Alexandersen P; Byrjalsen I; Christiansen C
BJOG; 2000 Mar; 107(3):356-64. PubMed ID: 10740332
[TBL] [Abstract][Full Text] [Related]
13. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.
Grey AB; Stapleton JP; Evans MC; Tatnell MA; Reid IR
Ann Intern Med; 1996 Sep; 125(5):360-8. PubMed ID: 8702086
[TBL] [Abstract][Full Text] [Related]
14. The effect of oestradiol implants on regional and total bone mass: a three-year longitudinal study.
Ryde SJ; Bowen-Simpkins K; Bowen-Simpkins P; Evans WD; Morgan WD; Compston JE
Clin Endocrinol (Oxf); 1994 Jan; 40(1):33-8. PubMed ID: 8306478
[TBL] [Abstract][Full Text] [Related]
15. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
Hosking D; Chilvers CE; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates AJ
N Engl J Med; 1998 Feb; 338(8):485-92. PubMed ID: 9443925
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal bone loss: does HRT always work?
Stevenson JC; Hillard TC; Lees B; Whitcroft SI; Ellerington MC; Whitehead MI
Int J Fertil Menopausal Stud; 1993; 38 Suppl 2():88-91. PubMed ID: 8252111
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis prevention clinical study program.
Delmas P; Gimona A
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
[TBL] [Abstract][Full Text] [Related]
18. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
Christiansen C; Riis BJ
Br J Obstet Gynaecol; 1990 Dec; 97(12):1087-92. PubMed ID: 2126198
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women.
Wide L; Naessén T; Phillips DJ
Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
